Product Information

POTASSIUM CITRATE ER 10 MEQ TB is a generic product labeled by BioComp Pharma Inc., priced at $0.1791 per EA under NDC 44523041001. Its NADAC has been published 85 times since Apr 9, 2025.

FDA first approved this application on Aug 30, 1985. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CITRATE ER 10 MEQ TB

potassium citrate
$0.1791per EA

Strength

10 meq/1

NDC

44523041001

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

POTASSIUM CITRATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA019071

FDA Approved

8/30/1985

TE Code

AB

On Market Since

12/3/2024

Pharmacological Classes

Acidifying Activity
Anti-coagulant
Calcium Chelating Activity
Calculi Dissolution Agent
Decreased Coagulation Factor Activity

Price Statistics

The NADAC for POTASSIUM CITRATE ER 10 MEQ TB has been published 85 times since Apr 9, 2025, and over the history we have for it it has declined 21.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1791 per EA
All-time high$0.2321 (May 14, 2025)
All-time low$0.1666 (Sep 17, 2025)
52-week high$0.1813
52-week low$0.1704
Median price$0.1785
Average price$0.1853
Largest weekly change-10.5% (Jul 23, 2025)
Weeks tracked85
Tracking sinceApr 9, 2025

Price History

1W

+3.6%

1M

+2.2%

3M

-0.4%

6M

+0.3%

1Y

+5.1%

3Y

N/A

5Y

N/A

All

-21.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of POTASSIUM CITRATE ER 10 MEQ TB?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CITRATE ER 10 MEQ TB, manufactured by BioComp Pharma Inc., is $0.1791 per EA (NDC 44523041001), effective Nov 18, 2026.

How has the price of POTASSIUM CITRATE ER 10 MEQ TB changed over time?

Over the history we have for it, the NADAC for POTASSIUM CITRATE ER 10 MEQ TB has declined 21.8%. It has been tracked across 85 weekly CMS publications since Apr 9, 2025.

What are the highest and lowest recorded NADAC prices for POTASSIUM CITRATE ER 10 MEQ TB?

Since Apr 9, 2025, the NADAC for POTASSIUM CITRATE ER 10 MEQ TB has ranged from a low of $0.1666 (Sep 17, 2025) to a high of $0.2321 (May 14, 2025), with a median of $0.1785 per EA.

Are there cheaper alternatives to POTASSIUM CITRATE ER 10 MEQ TB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CITRATE ER 10 MEQ TB in a comparable dosage form, but none are currently priced below it.

Who manufactures POTASSIUM CITRATE ER 10 MEQ TB?

POTASSIUM CITRATE ER 10 MEQ TB (NDC 44523041001) is labeled by BioComp Pharma Inc., and CMS classifies it as a generic product.